Ritter Implants offers high-quality amniotic membranes to meet the needs of dental professionals, as a leading supplier of dental amniotic biologics.

The spine biologics market is growing due to increasing spinal fusion procedures. Current trends include rising use of bone grafts and cell-based therapies.

ROS Aesthetics offers biologics treatments for skin, using natural and advanced solutions for rejuvenation, anti-aging, and healing, resulting in youthful skin.

Biologics are large molecule products used to treat many chronic diseases. Biosimilars are rated as highly similar versions of biologic therapies.

ACP & Biologics for Pain Management is organized by Empire Medical Training (EMT), Inc in New York City, USA.

The global orthobiologics market is expected to reach USD 9.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.31% during 2025-2033 (IMARC Group).

Key market growth factors include rising demand for orthobiologics by orthopedic surgeons, to promote faster healing of injuries, and increasing osteoarthritis prevalence.

Lexis Conferences hosts a Biosimilars & Biologics Summit in London, UK.

BiologicsPD.com offers bacterial, baculovirus, insect, yeast, and mammalian cell culture services in a bioreactor.

BiologicsCorp, based in Indianapolis, specializes in recombinant protein expression and purification. They provide cytokines, chemokines, growth factors, and viral antigens.

Features an extensive study of the current market landscape and future potential of top-selling biologics used for treating various disease indications.

Bio-Processing Alliance Inc. offers biologics development and cGMP manufacturing assistance to innovator and service companies. Services include technology transfer.

Comprehensive Biologics and Dr. Buzz advance healthcare through regenerative medicine. BiologicalMatrix-50, BiologicalMatrix Pro, and BiologicalAmnio are minimally manipulated allografts.

This resource offers information on vitamins.

The global biologics contract manufacturing market is projected to exceed $19 billion, with an estimated compound annual growth rate of approximately 9% during the forecast period.

Key factors increasing the orthobiologics market demand are the growing geriatric population, road accidents and sports injuries.

Orthopedic devices are used for restoring skeletal structure and joint movements in various fractures, abnormal growth of bones, soft tissue damage, trauma or other deformities.

Market research projects that the South Korea biologics market will grow at a compound annual growth rate (CAGR) of 7.06%.